Methods of treating or preventing neuropathic pain using sibutramine metabolites

   
   

Methods of making and using racemic and optically pure metabolites of sibutramine, and pharmaceutically acceptable salts, solvates, and clathrates thereof, are disclosed. Pharmaceutical compositions and dosage forms are also disclosed which comprise a dopamine reuptake inhibitor, such as a racemic or optically pure sibutramine metabolite, and optionally an additional pharmacologically active compound.

Показаны методы метаболитов делать и использования рацемических и оптически чисто sibutramine, и фармацевтически приемлемо соли, solvates, и клатраты thereof. Фармацевтические составы и формы дозировки также показаны состоят из иа АБС битор reuptake допамина, such as рацемический или оптически чисто метаболит sibutramine, и опционно дополнительной фармакологически активно смеси.

 
Web www.patentalert.com

< Ester or amide derivatives

< Combination of gaba agonists and aldose reductase Inhibitors

> Protected forms of pharmacologically active agents and uses therefor

> 3-heteroarylalkyl substituted gaba analogs

~ 00105